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ABSTRACT
Background: Potentiation of neuromuscular blocking agents by local anesthetics has been described in various clinical and 
experimental studies. This study assessed the influence of epidural ropivacaine on pharmacodynamic characteristics of rocuronium.
Design: This was a prospective randomized clinical trial at the women’s hospital, an university tertiary hospital in Brazil. 
Sixty‑two patients underwent elective abdominal surgeries requiring general anesthesia.
Intervention: Patients were distributed into two groups: Group 1 (general anesthesia and epidural anesthesia) and 
Group 2 (general anesthesia). In Group 1, 0.2% ropivacaine at a dose of 40 mg (20 ml) was associated with 2 mg (2 ml) of 
morphine in a single epidural injection. The following parameters were assessed: clinical duration (DC25) and time for recovery 
of the train‑of‑four (TOF) 0.9 ratio (T4/T1 = 90%) after an initial 0.6 mg/kg dose of rocuronium. The primary outcomes were 
DC25 and TOF 0.9 ratio (T4/T1 = 90%). Secondary outcomes were total propofol and remifentanil consumption.
Results: Values were presented as median and interquartile range. The results for DC25 and TOF 0.9 of rocuronium were, 
respectively, 41.5 35.0–55.0 (25.0–63.0) in Group 1 and 44.0 37.0‑51.0 (20.0–67.0) in Group 2 (P = 0.88); 88.0 67.0–99.0 
(43.0–137.0) in Group 1; and 80.0 71.0‑86.0 (38.0–155.0) in Group 2 (P = 0.83).  There was no significant difference between 
the groups, in terms of pharmacodynamic characteristics of rocuronium. Propofol consumption did not show any difference 
between the groups. However, remifentanil consumption was significantly lower in Group 1 (P < 0.01).
Conclusion: Epidural ropivacaine, in the dose studied, did not prolong the duration of rocuronium‑induced neuromuscular blockade.
Trial Registry Number: ReBEC (ref: RBR‑7cyp6t).
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Introduction
The interaction between local anaesthetics (AL) and 
nondepolarizing neuromuscular blocking agents has been 
studied both experimentally and in clinical trials.[1‑14] The 
currently common combination of general and regional 
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anesthesia is aimed at improving the quality of intra‑ and 
postoperative analgesia. This interaction is further 
emphasized since the influence of local anesthetics on 
the pharmacokinetic and pharmacodynamic properties of 
neuromuscular blocking drugs has already been described in 
the literature with consequent clinical relevance.[5‑9]
Nevertheless, none of these studies have assessed the interaction 
between ropivacaine, a local anesthetic known for its favorable 
cardiotoxic profile, and rocuronium, a neuromuscular blocking 
agent commonly used because of its short latency and specific 
antagonist available.[15,16] The purpose of the current study was 
to assess the influence of epidural ropivacaine on the duration 
of neuromuscular block produced by rocuronium.
Methods
The  cu r ren t  s tudy  was  approved  (Re f :  C A AE 
50852714.7.0000.5404) by the Research Ethics Committee 
of the State University of Campinas School of Medicine, 
Campinas, São Paulo, Brazil (Chairperson: Prof R. 
M. S. Celeghini) on December 21, 2015. This is an open 
and randomized clinical trial [Figure 1 for study profile 
according to the Consolidated Standards of Reporting 
Trials. After a written informed consent term was obtained, 
60 female patients, ASA I and II physical status, undergoing 
abdominal gynecological surgeries under general anesthesia 
associated or not with epidural block were included in the 
study. Exclusion criteria were prediction of difficult airway, 
neuromuscular, renal, and hepatic disorders; body mass 
index (BMI) higher than 30.0 or lower than 20.0 kg/m2; fluid 
and electrolyte imbalance and acid–base disorders; use of 
drugs that interact with neuromuscular blocking agents; 
contraindication to epidural anesthesia; and history of 
hypersensitivity reaction to drugs used.
Study protocol
From a list of random computer‑generated numbers, patients 
were distributed into two groups of 30 patients per group, 
according to anesthetic technique: Group 1 (epidural and 
general anesthesia) and Group 2 (general anesthesia).
The anesthetic procedures were performed by one of the 
anesthesiologists participating in the study, and data were 
collected by the main researchers.
All patients were fasted and premedicated with intravenous 
midazolam (2–3 mg), 5 min before the beginning of the 
Evaluated for eligibility (n = 92)  
Excluded (n = 30)
10 declined to participate
20 patients with exclusion criteria:
12 patients with difficult airway,
8 receiving drugs with action at
the neuromuscular junction
Randomized (n = 62)
Group 1 (n = 31)
• Received epidural anesthesia + general
  anesthesia (n = 30)
• Did not receive epidural anesthesia  +
  general (n = 0)
Group 2 (n = 31)
• Received general anesthesia (n = 30)
• Did not receive general anesthesia
  (n = 0)
Loss to follow-up (n = 1)
Curare dose required before data acquisition
Loss to follow-up (n = 1)
End of procedure before achieving
T4/T1 0.9
Analysed (n = 30)
• Excluded from analysis (n = 0)
Analyzed (n = 30)
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procedure. Continuous monitoring with cardioscopy 
in DII, pulse oximetry, noninvasive arterial pressure, 
capnography, and gas analyzer was performed. To evaluate 
neuromuscular block, a neuromuscular transmission 
monitor (Acceleromyographic train‑of‑four [TOF]‑GUARD) was 
employed. Surface electrodes were placed over the course of 
the ulnar nerve at the wrist contralateral to the dominant hand 
of the patient; the acceleration transducer (piezoelectric) was 
fixed on the distal phalange of the thumb of the index limb 
and a temperature probe over the skin of the thenar region. 
A “control” muscle response was obtained using isolated 
supramaximal stimuli (1 Hz) during 3 min, for stabilization 
of the response. After the induction of anesthesia and 
administration of rocuronium, neuromuscular function was 
monitored continuously, with a train‑of‑four sequence–
TOF. This study was based on the guidelines proposed by 
Fuchs‑Buder, aimed at avoiding other factors that could 
interfere in the pharmacodynamics of neuromuscular 
blocking agents.[17]
In Group 1 patients, the epidural block was performed with 
the patients in the sitting position. After local infiltration 
with 2% lidocaine (2–3 mL), an 18‑gauge Tuohy needle was 
introduced at the L3‑4 interspace, using the midline approach 
and loss of resistance to air technique for identification 
of the epidural space, followed by an injection of 20 ml 
0.2% ropivacaine (40 mg) associated with morphine (2 mg).
In both the groups, general anesthesia technique was induced 
with sufentanil (0.5 µg/kg) and propofol (2.0 mg/kg), followed 
by a dose of rocuronium (0.6 mg/kg) injected within 5 s. 
Patients received bag‑mask ventilation with 100% oxygen until 
the performance of laryngoscopy and tracheal intubation. 
Anesthesia was maintained with continuous infusions of 
propofol (5–7 mg/kg/h) and remifentanil (0.05–0.15 µg/kg/min), 
titrated according to each 5% variation on the cardiac frequency 
and mean blood pressures values. Furthermore, an oxygen 
and nitrous oxide gas mixture (50%) was administered, and the 
expired fraction of N2O was monitored, to provide amnesia since 
no monitor of anesthesia depth is available at our institution. 
Ventilatory parameters were adjusted to maintain expired 
CO2 (PETCO2) between 30 and 33 mmHg. Skin temperature on 
the tenar region was maintained between 30°C and 32°C.
Evaluation of neuromuscular block
The primary outcomes assessed were DC25% (clinical duration 
in minutes) – the time interval between rocuronium injection 
and spontaneous recovery of 25% of the amplitude of the first 
TOF‑evoked response (T1); time in minutes for spontaneous 
recovery of the TOF ratio (T4/T1 = 0.9).  Secondary outcomes 
were total propofol consumption and total remifentanil 
consumption.
Statistical analysis
The sample size was estimated considering data from a 
previous study conducted by Suzuki et al.[7] Those authors 
observed that the time between the administration of 
neuromuscular blocking agent and spontaneous recovery 
of the T4/T1 ratio = 0.9 was significantly longer (P < 0.01) 
in patients receiving local anesthetics by the epidural 
route, in comparison to those receiving only general 
anesthesia. Considering it clinically significant, a beta 
error = 20% (power = 80%) and alpha error = 5%, it was 
determined that sample size would be at least 28 patients 
per group.
For the data analysis, the Statistical Analysis System for 
Windows program version 9.2 was used. A comparison 
between categorical variables between both the groups was 
made with the Chi‑square test. Numerical variables were 
described using minimum and maximum values and median 
and quartiles and were analyzed using the Mann–Whitney 
U‑test. The level of significance adopted was 5% (P < 0.05).
Results
Of the 67 patients included and randomized for this study, five 
were excluded (two declined and three had some exclusion 
criterion) and 62 were enrolled and randomized between 
March 2015 and October 2017. One patient from each group 
was discontinued and excluded from the analysis (need of an 
additional dose of rocuronium before the data acquisition and 
end of the surgery prior to obtaining T4/T1 = 0.9); therefore, 
60 patients were analyzed according to the protocol.
No significant differences in age, height, weight, and BMI 
were found between the groups [Table 1].
There was no significant difference between the groups 
in patient distribution relative to physical status (ASA) 
(P = 0.42), values of expired CO2 (P = 0.47), and temperature 
(P = 0.14).
Surgical duration and propofol consumption did not show 
any difference between groups. However, remifentanil 
consumption was significantly lower in Group 1 (P < 0.01) 
[Table 2].
A comparative analysis also did not show a statistically 
significant difference between the groups regarding 
DC25 (P = 0.88) and TOF = 0.9 (P = 0.83) [Table 3]. 
Graphs 1 and 2 (boxplots) illustrates the analysis of values 
observed for these variables.
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Discussion
Although an interaction between local anesthetics and 
neuromuscular blocking agents has been described in the 
literature,[1‑14] the results of the current study have shown that 
epidural administration of ropivacaine did not significantly 
alter the clinical duration and time for spontaneous 
90% recovery in the T4/T1 ratio of rocuronium‑induced 
neuromuscular block. These results are contrary to the 
findings of other authors who described potentiation of 
neuromuscular block produced by different neuromuscular 
blocking agents in patients.[5‑8]
In contrast to findings observed in our study, the results 
of other studies may be attributed to the use of higher 
local anesthetic concentrations than those used in this 
study, in which ropivacaine was administered in analgesic 
concentrations (0.2%), implying a lower total mass of 
ropivacaine, and consequently, a lower plasma concentration 
of local anesthetic. Thus, the concentration of ropivacaine at 
the NMJ may have been insufficient and might explain the lack 
of influence on pharmacodynamic variables of rocuronium.
Furthermore, characteristics inherent to drugs studied 
may justify these differences. In a series of experimental 
studies, it was observed that different local anesthetics, 
including racemic bupivacaine, levobupivacaine, and 
lidocaine, interact with neuromuscular blocking agents 
at the neuromuscular junction and may have a pre‑ and 
postsynaptic action.[2,3,11‑13] Nevertheless, this interaction and 
potentiation of rocuronium‑induced neuromuscular block 
in diaphragm preparations of rats exposed to ropivacaine 
may be explained only by a presynaptic action of local 
anesthetics, shown by a decrease in the amplitude and 
frequency of miniature end‑plate potentials.[2] In addition, 
ropivacaine has stereoselective properties, characterized 
























Graph 1: Boxplots – Clinical duration  in Groups 1 and 2.  (x‑axis: Group; 
y‑axis: Clinical duration DC25)
Table 1: Physical characteristics of patients: Weight, height, and body mass index in Groups 1 and 2
Variables Groups Means SD Median IQR [xx-yy] P
Age (years) 1 40.9 7.7 43.0 35.0‑46.0 [26.0‑58.0] 0.70
2 40.6 11 40.0 32.0‑48.0 [17.0‑63.0]
Weight (kg) 1 73.1 10.5 72.0 66.0‑81.0 [52.0‑90.0] 0.139
2 69.1 11.2 79.0 58.0‑79.0 [52.0‑89.0]
Height (cm) 1 161.4 6.0 161.0 158.0‑165.0 [151.0‑176.0] 0.428
2 160.2 6.8 160.0 154.0‑165.0 [152.0‑178.0]
BMI (kg/m2) 1 27.0 3.7 28.0 25.9‑30.0 [20.0‑30.0] 0.209
2 28.0 5.0 25.9 23.0‑30.0 [20.0‑30.0]
*Mann‑Whitney U‑test. SD: Standard deviaton; IQR: Interquartile range; BMI: Body mass index
Table 2: Patient characteristics in relation to the variables surgical duration, total dose of propofol and remifentanil in Groups 1 and 2
Variables Groups Means SD Median IQR [xx-yy] P
Surgical duration (min) 1 128.5 29.4 128.0 102.0‑150.0 [73.0‑200.0] 0.15
2 116.4 32.8 118.5 90.0‑138.0 [60.0‑195.0]
Propofol dose (mg) 1 927.7 301.9 954.5 700.0‑1100.0 [330.0‑1893.0] 0.83
2 930.3 386.4 829.9 1206.0‑356.3 [356.3‑1698.0]
Remifentanil dose (µg) 1 574.0 367.3 550.5 300.0‑760.0 [0.0‑1300.0] <0.001
2 972.6 479.7 160.0 660.0‑1340.0 [27.0‑2000.0]
*Mann‑Whitney U‑test. SD: Standard deviaton; IQR: Interquartile range
Table 3: Clinical duration and time for recovery of TOF=90% in 
Groups 1 and 2
Variables Groups Means SD Median IQR [xx-yy] P
DC25 (min) 1 44.6 11.3 41.5 35.0‑55.0 [25.0‑63.0] 0.88
2 44.5 10.7 44.0 37.0‑51.0 [20.0‑67.0]
T4/T1 0.9 
(min)
1 87.4 23.6 88.0 67.0‑99.0 [43.0‑137.0] 0.83
2 82.3 21.2 80.0 71.0‑86.0 [38.0‑155.0]
*Mann‑Whitney U‑test. SD: Standard deviaton; IQR: Interquartile range; DC: Clinical 
duration; TOF: train‑of‑four
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Mechanisms of this interaction and its clinical implications, 
however, have still not been fully investigated. It has been 
described that local anesthetics have a multifactorial action 
at the neuromuscular junction that may involve depressed 
conduction of the presynaptic motor fiber, inhibiting 
ACh release during nerve stimulation, binding to different 
specific ACh sites, resulting in desensitization of receptors, 
temporary occlusion of nicotine receptors, stabilization of 
the postjunctional membrane, and interference with the 
excitation‑contraction coupling mechanism of the skeletal 
muscle fiber.[2,13,18]
This mechanism may convey an interaction of lower clinical 
relevance, with the use of analgesic concentrations in 
particular. Even in those studies that had statistically 
significant results,[5‑7] the increase in rocuronium‑induced 
neuromuscular block found may be of limited clinical 
relevance. Nevertheless, it is likely that we will be 
challenged by clinical settings where many clinical 
conditions and drugs used in the perioperative period, 
such as calcium blocking channels or halogenated agents, 
interact simultaneously compromising the neuromuscular 
transmission.
In addition, we observed that remifentanil consumption 
in Group 1 was shown to be significantly lower than in the 
group that did not receive epidural anesthesia. Thus, epidural 
ropivacaine, in the concentration and dose used, might 
be effective at increasing the quality of surgical analgesia, 
although our study was not powered to assess this finding.
It is also known that opioids have no activity at the 
neuromuscular junction and do not interact with 
neuromuscular blocking agents. It may be inferred that 
this finding had no influence on the pharmacodynamic 
characteristics of rocuronium.
In this study, although epidural ropivacaine did not increase 
the duration of rocuronium‑induced neuromuscular block in 
the 2 DE95 dose, the interaction between local anesthetics 
and neuromuscular blocking drugs is described. Confirmation 
of this interaction is of the utmost importance. Therefore, 
more frequent monitoring of the effects of neuromuscular 
blocking agents is recommended, particularly when these 
drugs are used simultaneously or in any situation in which the 
margin of safety of neuromuscular junction is compromised. 
In those situations, patients undergoing general anesthesia 
combined with epidural block may have more common 
complications that are related to a higher degree and 
duration of neuromuscular blockade, with a higher risk of 
postoperative residual block (curarization).
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